EI
EAM Investors Portfolio holdings
AUM
$660M
1-Year Return
271.72%
This Quarter Return
+24.73%
1 Year Return
+271.72%
3 Year Return
+5,059.16%
5 Year Return
+72,876.1%
10 Year Return
+9,525,914.37%
AUM
$866M
AUM Growth
+$149M
(+21%)
Cap. Flow
+$85M
Cap. Flow
% of AUM
9.82%
Top 10 Holdings %
Top 10 Hldgs %
7.14%
Holding
453
New
147
Increased
91
Reduced
74
Closed
130
Top Buys
| 1 |
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
|
+$6.48M |
| 2 |
CBM
Cambrex Corporation
CBM
|
+$5.5M |
| 3 |
CSII
Cardiovascular Systems, Inc.
CSII
|
+$5.34M |
| 4 |
RALY
RALLY SOFTWARE DEV CORP
RALY
|
+$5.05M |
| 5 |
Coherus Oncology, Inc. Common Stock
CHRS
|
+$4.97M |
Top Sells
| 1 |
Esperion Therapeutics
ESPR
|
+$8.77M |
| 2 |
IMPV
Imperva, Inc.
IMPV
|
+$5.46M |
| 3 |
RadNet
RDNT
|
+$5.41M |
| 4 |
PLNR
PLANAR SYSTEMS INC
PLNR
|
+$4.97M |
| 5 |
Motorcar Parts of America
MPAA
|
+$4.78M |
Sector Composition
| 1 | Healthcare | 23.59% |
| 2 | Technology | 18.66% |
| 3 | Consumer Discretionary | 13.65% |
| 4 | Industrials | 11.89% |
| 5 | Communication Services | 5.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
Old Dominion Freight Line
ODFL
$30.5B
| – | – |
-115,308
| Closed | -$2.98M |
|
377
ODP
ODP
$624M
| – | – |
-39,158
| Closed | -$3.36M |
|
378
Omnicell
OMCL
$1.46B
| – | – |
-75,219
| Closed | -$2.49M |
|
379
OneSpan
OSPN
$588M
| – | – |
-136,790
| Closed | -$3.86M |
|
380
OraSure Technologies
OSUR
$242M
| – | – |
-112,578
| Closed | -$1.14M |
|
381
Puma Biotechnology
PBYI
$225M
| – | – |
-10,379
| Closed | -$1.96M |
|
382
Pacira BioSciences
PCRX
$1.22B
| – | – |
-20,604
| Closed | -$1.83M |
|
383
Piper Sandler
PIPR
$6.12B
| – | – |
-19,001
| Closed | -$1.1M |
|
384
CarParts.com
PRTS
$44M
| – | – |
-72,745
| Closed | -$170K |
|
385
FreightCar America
RAIL
$162M
| – | – |
-78,177
| Closed | -$2.06M |
|
386
Radcom
RDCM
$234M
| – | – |
-53,528
| Closed | -$649K |
|
387
Radware
RDWR
$1.1B
| – | – |
-38,194
| Closed | -$841K |
|
|
RGLS
388
DELISTED
Regulus Therapeutics
RGLS
| – | – |
-499
| Closed | -$961K |
|
389
Simmons First National
SFNC
$2.96B
| – | – |
-54,660
| Closed | -$1.11M |
|
390
Synchronoss Technologies
SNCR
$66.9M
| – | – |
-6,065
| Closed | -$2.29M |
|
391
Steris
STE
$24.6B
| – | – |
-49,793
| Closed | -$3.23M |
|
392
Strategic Education
STRA
$1.98B
| – | – |
-14,367
| Closed | -$1.07M |
|
393
STRATTEC Security
STRT
$283M
| – | – |
-15,275
| Closed | -$1.26M |
|
394
Standex International
SXI
$2.47B
| – | – |
-48,167
| Closed | -$3.72M |
|
395
Synaptics
SYNA
$2.72B
| – | – |
-28,674
| Closed | -$1.97M |
|
396
TriNet
TNET
$3.35B
| – | – |
-84,302
| Closed | -$2.64M |
|
397
Tempest Therapeutics
TPST
$45.5M
| – | – |
-8
| Closed | -$982K |
|
398
TrueCar
TRUE
$215M
| – | – |
-103,826
| Closed | -$2.38M |
|
399
Universal Electronics
UEIC
$62.3M
| – | – |
-24,673
| Closed | -$1.6M |
|
400
Visteon
VC
$3.4B
| – | – |
-24,287
| Closed | -$2.6M |
|